National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Understanding Cancer Series: Estrogen Receptors/SERMs
< Back to Main
    Posted: 01/28/2005    Updated: 04/27/2006    Reviewed: 09/01/2006
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Slide 7  :  Estrogen and Cancer <  >  

Paradoxically, estrogen can be both a beneficial and a harmful molecule.

The main beneficial effects of estrogen include its roles in

  1. programming the breast and uterus for sexual reproduction,
  2. controlling cholesterol production in ways that limit the buildup of plaque in the coronary arteries, and
  3. preserving bone strength by helping to maintain the proper balance between bone buildup and breakdown.

Unfortunately, in addition to these important beneficial effects, estrogen can also be harmful. The most serious problem arises from the ability of estrogen to promote the proliferation of cells in the breast and uterus. Although this ability to stimulate cell proliferation is one of estrogen's normal roles, it can also increase a woman's chance of developing breast or uterine cancer.

Estrogen and Cancer

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov